nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB1—coronary artery disease	0.107	0.39	CbGaD
Metoprolol—Oxprenolol—Penbutolol—coronary artery disease	0.0917	0.391	CrCrCtD
Metoprolol—Alprenolol—Penbutolol—coronary artery disease	0.0917	0.391	CrCrCtD
Metoprolol—ADRB2—coronary artery disease	0.0899	0.328	CbGaD
Metoprolol—CYP2C19—coronary artery disease	0.0774	0.282	CbGaD
Metoprolol—Propranolol—Penbutolol—coronary artery disease	0.0512	0.218	CrCrCtD
Metoprolol—ADRB2—Penbutolol—coronary artery disease	0.0322	0.0984	CbGbCtD
Metoprolol—ADRB1—Penbutolol—coronary artery disease	0.0317	0.0969	CbGbCtD
Metoprolol—ADRB2—Timolol—coronary artery disease	0.0227	0.0693	CbGbCtD
Metoprolol—ADRB1—Timolol—coronary artery disease	0.0223	0.0683	CbGbCtD
Metoprolol—ABCB1—Ticagrelor—coronary artery disease	0.0139	0.0424	CbGbCtD
Metoprolol—CYP2C19—Gemfibrozil—coronary artery disease	0.0123	0.0374	CbGbCtD
Metoprolol—CYP2C19—Clopidogrel—coronary artery disease	0.0106	0.0325	CbGbCtD
Metoprolol—CYP2C19—Telmisartan—coronary artery disease	0.00929	0.0284	CbGbCtD
Metoprolol—ABCB1—Perindopril—coronary artery disease	0.00857	0.0262	CbGbCtD
Metoprolol—ABCB1—Clopidogrel—coronary artery disease	0.00857	0.0262	CbGbCtD
Metoprolol—ABCB1—Telmisartan—coronary artery disease	0.00749	0.0229	CbGbCtD
Metoprolol—ABCB1—Pitavastatin—coronary artery disease	0.00749	0.0229	CbGbCtD
Metoprolol—CYP2C19—Timolol—coronary artery disease	0.00749	0.0229	CbGbCtD
Metoprolol—ABCB1—Enalapril—coronary artery disease	0.0071	0.0217	CbGbCtD
Metoprolol—ABCB1—Lisinopril—coronary artery disease	0.0071	0.0217	CbGbCtD
Metoprolol—CYP2C19—Rosuvastatin—coronary artery disease	0.00685	0.0209	CbGbCtD
Metoprolol—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00667	0.0204	CbGbCtD
Metoprolol—CYP2C19—Simvastatin—coronary artery disease	0.00636	0.0194	CbGbCtD
Metoprolol—CYP2C19—Lovastatin—coronary artery disease	0.00623	0.019	CbGbCtD
Metoprolol—CYP2D6—Niacin—coronary artery disease	0.00612	0.0187	CbGbCtD
Metoprolol—ABCB1—Timolol—coronary artery disease	0.00604	0.0184	CbGbCtD
Metoprolol—CYP2D6—Timolol—coronary artery disease	0.00569	0.0174	CbGbCtD
Metoprolol—CYP2C19—Atorvastatin—coronary artery disease	0.00567	0.0173	CbGbCtD
Metoprolol—ABCB1—Ezetimibe—coronary artery disease	0.00552	0.0169	CbGbCtD
Metoprolol—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00538	0.0164	CbGbCtD
Metoprolol—ABCB1—Captopril—coronary artery disease	0.00532	0.0162	CbGbCtD
Metoprolol—CYP2C19—Losartan—coronary artery disease	0.00519	0.0158	CbGbCtD
Metoprolol—ABCB1—Simvastatin—coronary artery disease	0.00514	0.0157	CbGbCtD
Metoprolol—ABCB1—Lovastatin—coronary artery disease	0.00503	0.0154	CbGbCtD
Metoprolol—ABCB1—Pravastatin—coronary artery disease	0.00503	0.0154	CbGbCtD
Metoprolol—CYP2D6—Captopril—coronary artery disease	0.00501	0.0153	CbGbCtD
Metoprolol—CYP2D6—Simvastatin—coronary artery disease	0.00484	0.0148	CbGbCtD
Metoprolol—CYP2D6—Pravastatin—coronary artery disease	0.00474	0.0145	CbGbCtD
Metoprolol—CYP2D6—Lovastatin—coronary artery disease	0.00474	0.0145	CbGbCtD
Metoprolol—ABCB1—Atorvastatin—coronary artery disease	0.00458	0.014	CbGbCtD
Metoprolol—CYP2D6—Atorvastatin—coronary artery disease	0.00431	0.0132	CbGbCtD
Metoprolol—ABCB1—Losartan—coronary artery disease	0.00419	0.0128	CbGbCtD
Metoprolol—Practolol—ADRB1—coronary artery disease	0.000193	0.0664	CrCbGaD
Metoprolol—Metipranolol—ADRB1—coronary artery disease	0.000174	0.0601	CrCbGaD
Metoprolol—Sotalol—ADRB1—coronary artery disease	0.000155	0.0535	CrCbGaD
Metoprolol—Metipranolol—ADRB2—coronary artery disease	0.000146	0.0505	CrCbGaD
Metoprolol—Esmolol—ADRB1—coronary artery disease	0.000138	0.0477	CrCbGaD
Metoprolol—Bevantolol—ADRB1—coronary artery disease	0.000137	0.0471	CrCbGaD
Metoprolol—Sotalol—ADRB2—coronary artery disease	0.000131	0.045	CrCbGaD
Metoprolol—Betaxolol—ADRB1—coronary artery disease	0.000122	0.042	CrCbGaD
Metoprolol—Atenolol—ADRB1—coronary artery disease	0.000121	0.0416	CrCbGaD
Metoprolol—Bisoprolol—ADRB1—coronary artery disease	0.000118	0.0406	CrCbGaD
Metoprolol—Esmolol—ADRB2—coronary artery disease	0.000116	0.0401	CrCbGaD
Metoprolol—Bevantolol—ADRB2—coronary artery disease	0.000115	0.0396	CrCbGaD
Metoprolol—Acebutolol—ADRB1—coronary artery disease	0.000111	0.0384	CrCbGaD
Metoprolol—Oxprenolol—ADRB1—coronary artery disease	0.000111	0.0381	CrCbGaD
Metoprolol—Betaxolol—ADRB2—coronary artery disease	0.000102	0.0353	CrCbGaD
Metoprolol—Atenolol—ADRB2—coronary artery disease	0.000102	0.035	CrCbGaD
Metoprolol—Alprenolol—ADRB1—coronary artery disease	0.000101	0.0349	CrCbGaD
Metoprolol—Bisoprolol—ADRB2—coronary artery disease	9.89e-05	0.0341	CrCbGaD
Metoprolol—Acebutolol—ADRB2—coronary artery disease	9.37e-05	0.0323	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—coronary artery disease	9.3e-05	0.0321	CrCbGaD
Metoprolol—Pindolol—ADRB1—coronary artery disease	8.7e-05	0.03	CrCbGaD
Metoprolol—Alprenolol—ADRB2—coronary artery disease	8.51e-05	0.0293	CrCbGaD
Metoprolol—Pindolol—ADRB2—coronary artery disease	7.32e-05	0.0252	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—coronary artery disease	5.44e-05	0.0188	CrCbGaD
Metoprolol—Propranolol—ADRB1—coronary artery disease	4.75e-05	0.0164	CrCbGaD
Metoprolol—Propranolol—ADRB2—coronary artery disease	3.99e-05	0.0138	CrCbGaD
Metoprolol—Propranolol—CYP2C19—coronary artery disease	3.44e-05	0.0119	CrCbGaD
Metoprolol—Vomiting—Ezetimibe—coronary artery disease	3.14e-05	0.000249	CcSEcCtD
Metoprolol—Hypersensitivity—Pravastatin—coronary artery disease	3.13e-05	0.000249	CcSEcCtD
Metoprolol—Gastrointestinal pain—Perindopril—coronary artery disease	3.13e-05	0.000249	CcSEcCtD
Metoprolol—Anxiety—Timolol—coronary artery disease	3.13e-05	0.000249	CcSEcCtD
Metoprolol—Pruritus—Olmesartan—coronary artery disease	3.13e-05	0.000249	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	3.12e-05	0.000248	CcSEcCtD
Metoprolol—Abdominal pain—Captopril—coronary artery disease	3.12e-05	0.000248	CcSEcCtD
Metoprolol—Body temperature increased—Captopril—coronary artery disease	3.12e-05	0.000248	CcSEcCtD
Metoprolol—Dizziness—Simvastatin—coronary artery disease	3.11e-05	0.000247	CcSEcCtD
Metoprolol—Rash—Ezetimibe—coronary artery disease	3.11e-05	0.000247	CcSEcCtD
Metoprolol—Dermatitis—Ezetimibe—coronary artery disease	3.11e-05	0.000247	CcSEcCtD
Metoprolol—Confusional state—Ramipril—coronary artery disease	3.11e-05	0.000247	CcSEcCtD
Metoprolol—Asthenia—Niacin—coronary artery disease	3.1e-05	0.000246	CcSEcCtD
Metoprolol—Fatigue—Losartan—coronary artery disease	3.1e-05	0.000246	CcSEcCtD
Metoprolol—Headache—Ezetimibe—coronary artery disease	3.09e-05	0.000246	CcSEcCtD
Metoprolol—Oedema—Ramipril—coronary artery disease	3.08e-05	0.000245	CcSEcCtD
Metoprolol—Vertigo—Lisinopril—coronary artery disease	3.07e-05	0.000245	CcSEcCtD
Metoprolol—Dry mouth—Timolol—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Pain—Losartan—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Constipation—Losartan—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Syncope—Lisinopril—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Vomiting—Eplerenone—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Feeling abnormal—Furosemide—coronary artery disease	3.07e-05	0.000244	CcSEcCtD
Metoprolol—Leukopenia—Lisinopril—coronary artery disease	3.06e-05	0.000244	CcSEcCtD
Metoprolol—Nausea—Fenofibrate—coronary artery disease	3.06e-05	0.000243	CcSEcCtD
Metoprolol—Pruritus—Niacin—coronary artery disease	3.05e-05	0.000243	CcSEcCtD
Metoprolol—Asthenia—Pravastatin—coronary artery disease	3.05e-05	0.000243	CcSEcCtD
Metoprolol—Gastrointestinal pain—Furosemide—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Rash—Eplerenone—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Urticaria—Perindopril—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Hypersensitivity—Trandolapril—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Dermatitis—Eplerenone—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Diarrhoea—Valsartan—coronary artery disease	3.04e-05	0.000242	CcSEcCtD
Metoprolol—Confusional state—Timolol—coronary artery disease	3.04e-05	0.000241	CcSEcCtD
Metoprolol—Shock—Ramipril—coronary artery disease	3.03e-05	0.000241	CcSEcCtD
Metoprolol—Hypersensitivity—Enalapril—coronary artery disease	3.03e-05	0.000241	CcSEcCtD
Metoprolol—Abdominal pain—Perindopril—coronary artery disease	3.03e-05	0.000241	CcSEcCtD
Metoprolol—Body temperature increased—Perindopril—coronary artery disease	3.03e-05	0.000241	CcSEcCtD
Metoprolol—Palpitations—Lisinopril—coronary artery disease	3.02e-05	0.000241	CcSEcCtD
Metoprolol—Diarrhoea—Olmesartan—coronary artery disease	3.02e-05	0.000241	CcSEcCtD
Metoprolol—Headache—Eplerenone—coronary artery disease	3.02e-05	0.000241	CcSEcCtD
Metoprolol—Nervous system disorder—Ramipril—coronary artery disease	3.02e-05	0.00024	CcSEcCtD
Metoprolol—Thrombocytopenia—Ramipril—coronary artery disease	3.02e-05	0.00024	CcSEcCtD
Metoprolol—Oedema—Timolol—coronary artery disease	3.01e-05	0.000239	CcSEcCtD
Metoprolol—Pruritus—Pravastatin—coronary artery disease	3.01e-05	0.000239	CcSEcCtD
Metoprolol—Loss of consciousness—Lisinopril—coronary artery disease	3.01e-05	0.000239	CcSEcCtD
Metoprolol—Nausea—Clopidogrel—coronary artery disease	3.01e-05	0.000239	CcSEcCtD
Metoprolol—Tachycardia—Ramipril—coronary artery disease	3.01e-05	0.000239	CcSEcCtD
Metoprolol—Skin disorder—Ramipril—coronary artery disease	2.99e-05	0.000238	CcSEcCtD
Metoprolol—Vomiting—Simvastatin—coronary artery disease	2.99e-05	0.000238	CcSEcCtD
Metoprolol—Hypersensitivity—Telmisartan—coronary artery disease	2.99e-05	0.000238	CcSEcCtD
Metoprolol—Nausea—Lovastatin—coronary artery disease	2.99e-05	0.000238	CcSEcCtD
Metoprolol—Hyperhidrosis—Ramipril—coronary artery disease	2.98e-05	0.000237	CcSEcCtD
Metoprolol—Rash—Simvastatin—coronary artery disease	2.96e-05	0.000236	CcSEcCtD
Metoprolol—Dermatitis—Simvastatin—coronary artery disease	2.96e-05	0.000236	CcSEcCtD
Metoprolol—Asthenia—Trandolapril—coronary artery disease	2.96e-05	0.000236	CcSEcCtD
Metoprolol—Shock—Timolol—coronary artery disease	2.96e-05	0.000236	CcSEcCtD
Metoprolol—Feeling abnormal—Losartan—coronary artery disease	2.96e-05	0.000235	CcSEcCtD
Metoprolol—Urticaria—Furosemide—coronary artery disease	2.96e-05	0.000235	CcSEcCtD
Metoprolol—Diarrhoea—Niacin—coronary artery disease	2.95e-05	0.000235	CcSEcCtD
Metoprolol—Nervous system disorder—Timolol—coronary artery disease	2.95e-05	0.000235	CcSEcCtD
Metoprolol—Asthenia—Enalapril—coronary artery disease	2.95e-05	0.000235	CcSEcCtD
Metoprolol—Headache—Simvastatin—coronary artery disease	2.95e-05	0.000234	CcSEcCtD
Metoprolol—Abdominal pain—Furosemide—coronary artery disease	2.94e-05	0.000234	CcSEcCtD
Metoprolol—Body temperature increased—Furosemide—coronary artery disease	2.94e-05	0.000234	CcSEcCtD
Metoprolol—Gastrointestinal pain—Losartan—coronary artery disease	2.94e-05	0.000234	CcSEcCtD
Metoprolol—Dizziness—Valsartan—coronary artery disease	2.94e-05	0.000234	CcSEcCtD
Metoprolol—Nausea—Ezetimibe—coronary artery disease	2.93e-05	0.000233	CcSEcCtD
Metoprolol—Skin disorder—Timolol—coronary artery disease	2.92e-05	0.000233	CcSEcCtD
Metoprolol—Dizziness—Olmesartan—coronary artery disease	2.92e-05	0.000232	CcSEcCtD
Metoprolol—Pruritus—Trandolapril—coronary artery disease	2.92e-05	0.000232	CcSEcCtD
Metoprolol—Arthralgia—Lisinopril—coronary artery disease	2.91e-05	0.000232	CcSEcCtD
Metoprolol—Chest pain—Lisinopril—coronary artery disease	2.91e-05	0.000232	CcSEcCtD
Metoprolol—Hyperhidrosis—Timolol—coronary artery disease	2.91e-05	0.000232	CcSEcCtD
Metoprolol—Asthenia—Telmisartan—coronary artery disease	2.91e-05	0.000231	CcSEcCtD
Metoprolol—Pruritus—Enalapril—coronary artery disease	2.91e-05	0.000231	CcSEcCtD
Metoprolol—Diarrhoea—Pravastatin—coronary artery disease	2.91e-05	0.000231	CcSEcCtD
Metoprolol—Anxiety—Lisinopril—coronary artery disease	2.9e-05	0.000231	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.89e-05	0.00023	CcSEcCtD
Metoprolol—Hypotension—Ramipril—coronary artery disease	2.88e-05	0.000229	CcSEcCtD
Metoprolol—Pruritus—Telmisartan—coronary artery disease	2.87e-05	0.000228	CcSEcCtD
Metoprolol—Nausea—Eplerenone—coronary artery disease	2.87e-05	0.000228	CcSEcCtD
Metoprolol—Dizziness—Niacin—coronary artery disease	2.86e-05	0.000227	CcSEcCtD
Metoprolol—Urticaria—Losartan—coronary artery disease	2.85e-05	0.000227	CcSEcCtD
Metoprolol—Dry mouth—Lisinopril—coronary artery disease	2.85e-05	0.000227	CcSEcCtD
Metoprolol—Abdominal pain—Losartan—coronary artery disease	2.84e-05	0.000226	CcSEcCtD
Metoprolol—Body temperature increased—Losartan—coronary artery disease	2.84e-05	0.000226	CcSEcCtD
Metoprolol—Asthenia—Captopril—coronary artery disease	2.83e-05	0.000225	CcSEcCtD
Metoprolol—Diarrhoea—Trandolapril—coronary artery disease	2.82e-05	0.000225	CcSEcCtD
Metoprolol—Vomiting—Valsartan—coronary artery disease	2.82e-05	0.000225	CcSEcCtD
Metoprolol—Confusional state—Lisinopril—coronary artery disease	2.82e-05	0.000224	CcSEcCtD
Metoprolol—Diarrhoea—Enalapril—coronary artery disease	2.81e-05	0.000224	CcSEcCtD
Metoprolol—Hypotension—Timolol—coronary artery disease	2.81e-05	0.000224	CcSEcCtD
Metoprolol—Dizziness—Pravastatin—coronary artery disease	2.81e-05	0.000224	CcSEcCtD
Metoprolol—Vomiting—Olmesartan—coronary artery disease	2.81e-05	0.000224	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.81e-05	0.000223	CcSEcCtD
Metoprolol—Rash—Valsartan—coronary artery disease	2.8e-05	0.000223	CcSEcCtD
Metoprolol—Dermatitis—Valsartan—coronary artery disease	2.8e-05	0.000223	CcSEcCtD
Metoprolol—Nausea—Simvastatin—coronary artery disease	2.79e-05	0.000222	CcSEcCtD
Metoprolol—Oedema—Lisinopril—coronary artery disease	2.79e-05	0.000222	CcSEcCtD
Metoprolol—Pruritus—Captopril—coronary artery disease	2.79e-05	0.000222	CcSEcCtD
Metoprolol—Rash—Olmesartan—coronary artery disease	2.79e-05	0.000222	CcSEcCtD
Metoprolol—Insomnia—Ramipril—coronary artery disease	2.79e-05	0.000222	CcSEcCtD
Metoprolol—Dermatitis—Olmesartan—coronary artery disease	2.78e-05	0.000221	CcSEcCtD
Metoprolol—Headache—Valsartan—coronary artery disease	2.78e-05	0.000221	CcSEcCtD
Metoprolol—Diarrhoea—Telmisartan—coronary artery disease	2.77e-05	0.000221	CcSEcCtD
Metoprolol—Headache—Olmesartan—coronary artery disease	2.77e-05	0.00022	CcSEcCtD
Metoprolol—Paraesthesia—Ramipril—coronary artery disease	2.77e-05	0.00022	CcSEcCtD
Metoprolol—Shock—Lisinopril—coronary artery disease	2.75e-05	0.000219	CcSEcCtD
Metoprolol—Asthenia—Perindopril—coronary artery disease	2.75e-05	0.000219	CcSEcCtD
Metoprolol—Dyspnoea—Ramipril—coronary artery disease	2.75e-05	0.000218	CcSEcCtD
Metoprolol—Vomiting—Niacin—coronary artery disease	2.75e-05	0.000218	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Timolol—coronary artery disease	2.74e-05	0.000218	CcSEcCtD
Metoprolol—Hypersensitivity—Furosemide—coronary artery disease	2.74e-05	0.000218	CcSEcCtD
Metoprolol—Somnolence—Ramipril—coronary artery disease	2.74e-05	0.000218	CcSEcCtD
Metoprolol—Thrombocytopenia—Lisinopril—coronary artery disease	2.73e-05	0.000218	CcSEcCtD
Metoprolol—Dizziness—Trandolapril—coronary artery disease	2.73e-05	0.000217	CcSEcCtD
Metoprolol—Tachycardia—Lisinopril—coronary artery disease	2.73e-05	0.000217	CcSEcCtD
Metoprolol—Insomnia—Timolol—coronary artery disease	2.72e-05	0.000217	CcSEcCtD
Metoprolol—Rash—Niacin—coronary artery disease	2.72e-05	0.000217	CcSEcCtD
Metoprolol—Dermatitis—Niacin—coronary artery disease	2.72e-05	0.000216	CcSEcCtD
Metoprolol—Dizziness—Enalapril—coronary artery disease	2.72e-05	0.000216	CcSEcCtD
Metoprolol—Skin disorder—Lisinopril—coronary artery disease	2.71e-05	0.000216	CcSEcCtD
Metoprolol—Dyspepsia—Ramipril—coronary artery disease	2.71e-05	0.000216	CcSEcCtD
Metoprolol—Pruritus—Perindopril—coronary artery disease	2.71e-05	0.000216	CcSEcCtD
Metoprolol—Headache—Niacin—coronary artery disease	2.7e-05	0.000215	CcSEcCtD
Metoprolol—Paraesthesia—Timolol—coronary artery disease	2.7e-05	0.000215	CcSEcCtD
Metoprolol—Vomiting—Pravastatin—coronary artery disease	2.7e-05	0.000215	CcSEcCtD
Metoprolol—Hyperhidrosis—Lisinopril—coronary artery disease	2.7e-05	0.000215	CcSEcCtD
Metoprolol—Diarrhoea—Captopril—coronary artery disease	2.7e-05	0.000215	CcSEcCtD
Metoprolol—Dyspnoea—Timolol—coronary artery disease	2.68e-05	0.000214	CcSEcCtD
Metoprolol—Dizziness—Telmisartan—coronary artery disease	2.68e-05	0.000213	CcSEcCtD
Metoprolol—Rash—Pravastatin—coronary artery disease	2.68e-05	0.000213	CcSEcCtD
Metoprolol—Dermatitis—Pravastatin—coronary artery disease	2.68e-05	0.000213	CcSEcCtD
Metoprolol—Somnolence—Timolol—coronary artery disease	2.68e-05	0.000213	CcSEcCtD
Metoprolol—Asthenia—Furosemide—coronary artery disease	2.67e-05	0.000212	CcSEcCtD
Metoprolol—Headache—Pravastatin—coronary artery disease	2.66e-05	0.000212	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Ramipril—coronary artery disease	2.66e-05	0.000212	CcSEcCtD
Metoprolol—Fatigue—Ramipril—coronary artery disease	2.65e-05	0.000211	CcSEcCtD
Metoprolol—Dyspepsia—Timolol—coronary artery disease	2.65e-05	0.000211	CcSEcCtD
Metoprolol—Hypersensitivity—Losartan—coronary artery disease	2.65e-05	0.00021	CcSEcCtD
Metoprolol—Nausea—Valsartan—coronary artery disease	2.64e-05	0.00021	CcSEcCtD
Metoprolol—Pruritus—Furosemide—coronary artery disease	2.63e-05	0.00021	CcSEcCtD
Metoprolol—Constipation—Ramipril—coronary artery disease	2.63e-05	0.000209	CcSEcCtD
Metoprolol—Nausea—Olmesartan—coronary artery disease	2.62e-05	0.000209	CcSEcCtD
Metoprolol—Vomiting—Trandolapril—coronary artery disease	2.62e-05	0.000209	CcSEcCtD
Metoprolol—Diarrhoea—Perindopril—coronary artery disease	2.62e-05	0.000208	CcSEcCtD
Metoprolol—Vomiting—Enalapril—coronary artery disease	2.61e-05	0.000208	CcSEcCtD
Metoprolol—Hypotension—Lisinopril—coronary artery disease	2.61e-05	0.000208	CcSEcCtD
Metoprolol—Dizziness—Captopril—coronary artery disease	2.61e-05	0.000207	CcSEcCtD
Metoprolol—Rash—Trandolapril—coronary artery disease	2.6e-05	0.000207	CcSEcCtD
Metoprolol—Dermatitis—Trandolapril—coronary artery disease	2.6e-05	0.000207	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Timolol—coronary artery disease	2.6e-05	0.000207	CcSEcCtD
Metoprolol—Fatigue—Timolol—coronary artery disease	2.6e-05	0.000206	CcSEcCtD
Metoprolol—Rash—Enalapril—coronary artery disease	2.59e-05	0.000206	CcSEcCtD
Metoprolol—Dermatitis—Enalapril—coronary artery disease	2.59e-05	0.000206	CcSEcCtD
Metoprolol—Headache—Trandolapril—coronary artery disease	2.59e-05	0.000206	CcSEcCtD
Metoprolol—Vomiting—Telmisartan—coronary artery disease	2.58e-05	0.000205	CcSEcCtD
Metoprolol—Asthenia—Losartan—coronary artery disease	2.58e-05	0.000205	CcSEcCtD
Metoprolol—Headache—Enalapril—coronary artery disease	2.58e-05	0.000205	CcSEcCtD
Metoprolol—Pain—Timolol—coronary artery disease	2.57e-05	0.000205	CcSEcCtD
Metoprolol—Nausea—Niacin—coronary artery disease	2.56e-05	0.000204	CcSEcCtD
Metoprolol—Rash—Telmisartan—coronary artery disease	2.56e-05	0.000203	CcSEcCtD
Metoprolol—Dermatitis—Telmisartan—coronary artery disease	2.55e-05	0.000203	CcSEcCtD
Metoprolol—Diarrhoea—Furosemide—coronary artery disease	2.55e-05	0.000203	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.54e-05	0.000202	CcSEcCtD
Metoprolol—Pruritus—Losartan—coronary artery disease	2.54e-05	0.000202	CcSEcCtD
Metoprolol—Headache—Telmisartan—coronary artery disease	2.54e-05	0.000202	CcSEcCtD
Metoprolol—Feeling abnormal—Ramipril—coronary artery disease	2.54e-05	0.000202	CcSEcCtD
Metoprolol—Dizziness—Perindopril—coronary artery disease	2.53e-05	0.000201	CcSEcCtD
Metoprolol—Insomnia—Lisinopril—coronary artery disease	2.53e-05	0.000201	CcSEcCtD
Metoprolol—Nausea—Pravastatin—coronary artery disease	2.53e-05	0.000201	CcSEcCtD
Metoprolol—Gastrointestinal pain—Ramipril—coronary artery disease	2.52e-05	0.0002	CcSEcCtD
Metoprolol—Paraesthesia—Lisinopril—coronary artery disease	2.51e-05	0.0002	CcSEcCtD
Metoprolol—Vomiting—Captopril—coronary artery disease	2.51e-05	0.000199	CcSEcCtD
Metoprolol—Dyspnoea—Lisinopril—coronary artery disease	2.49e-05	0.000198	CcSEcCtD
Metoprolol—Rash—Captopril—coronary artery disease	2.49e-05	0.000198	CcSEcCtD
Metoprolol—Dermatitis—Captopril—coronary artery disease	2.48e-05	0.000198	CcSEcCtD
Metoprolol—Somnolence—Lisinopril—coronary artery disease	2.48e-05	0.000198	CcSEcCtD
Metoprolol—Feeling abnormal—Timolol—coronary artery disease	2.48e-05	0.000197	CcSEcCtD
Metoprolol—Headache—Captopril—coronary artery disease	2.47e-05	0.000197	CcSEcCtD
Metoprolol—Gastrointestinal pain—Timolol—coronary artery disease	2.46e-05	0.000196	CcSEcCtD
Metoprolol—Dizziness—Furosemide—coronary artery disease	2.46e-05	0.000196	CcSEcCtD
Metoprolol—Dyspepsia—Lisinopril—coronary artery disease	2.46e-05	0.000196	CcSEcCtD
Metoprolol—Diarrhoea—Losartan—coronary artery disease	2.46e-05	0.000195	CcSEcCtD
Metoprolol—Nausea—Trandolapril—coronary artery disease	2.45e-05	0.000195	CcSEcCtD
Metoprolol—Urticaria—Ramipril—coronary artery disease	2.45e-05	0.000195	CcSEcCtD
Metoprolol—Nausea—Enalapril—coronary artery disease	2.44e-05	0.000194	CcSEcCtD
Metoprolol—Vomiting—Perindopril—coronary artery disease	2.43e-05	0.000194	CcSEcCtD
Metoprolol—Abdominal pain—Ramipril—coronary artery disease	2.43e-05	0.000194	CcSEcCtD
Metoprolol—Body temperature increased—Ramipril—coronary artery disease	2.43e-05	0.000194	CcSEcCtD
Metoprolol—Rash—Perindopril—coronary artery disease	2.41e-05	0.000192	CcSEcCtD
Metoprolol—Dermatitis—Perindopril—coronary artery disease	2.41e-05	0.000192	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.41e-05	0.000192	CcSEcCtD
Metoprolol—Nausea—Telmisartan—coronary artery disease	2.41e-05	0.000192	CcSEcCtD
Metoprolol—Fatigue—Lisinopril—coronary artery disease	2.41e-05	0.000192	CcSEcCtD
Metoprolol—Headache—Perindopril—coronary artery disease	2.4e-05	0.000191	CcSEcCtD
Metoprolol—Urticaria—Timolol—coronary artery disease	2.39e-05	0.00019	CcSEcCtD
Metoprolol—Constipation—Lisinopril—coronary artery disease	2.39e-05	0.00019	CcSEcCtD
Metoprolol—Pain—Lisinopril—coronary artery disease	2.39e-05	0.00019	CcSEcCtD
Metoprolol—Body temperature increased—Timolol—coronary artery disease	2.38e-05	0.000189	CcSEcCtD
Metoprolol—Abdominal pain—Timolol—coronary artery disease	2.38e-05	0.000189	CcSEcCtD
Metoprolol—Dizziness—Losartan—coronary artery disease	2.37e-05	0.000189	CcSEcCtD
Metoprolol—Vomiting—Furosemide—coronary artery disease	2.37e-05	0.000188	CcSEcCtD
Metoprolol—Rash—Furosemide—coronary artery disease	2.35e-05	0.000187	CcSEcCtD
Metoprolol—Dermatitis—Furosemide—coronary artery disease	2.34e-05	0.000187	CcSEcCtD
Metoprolol—Nausea—Captopril—coronary artery disease	2.34e-05	0.000186	CcSEcCtD
Metoprolol—Headache—Furosemide—coronary artery disease	2.33e-05	0.000186	CcSEcCtD
Metoprolol—Feeling abnormal—Lisinopril—coronary artery disease	2.3e-05	0.000183	CcSEcCtD
Metoprolol—Gastrointestinal pain—Lisinopril—coronary artery disease	2.28e-05	0.000182	CcSEcCtD
Metoprolol—Vomiting—Losartan—coronary artery disease	2.28e-05	0.000182	CcSEcCtD
Metoprolol—Nausea—Perindopril—coronary artery disease	2.27e-05	0.000181	CcSEcCtD
Metoprolol—Hypersensitivity—Ramipril—coronary artery disease	2.27e-05	0.00018	CcSEcCtD
Metoprolol—Rash—Losartan—coronary artery disease	2.26e-05	0.00018	CcSEcCtD
Metoprolol—Dermatitis—Losartan—coronary artery disease	2.26e-05	0.00018	CcSEcCtD
Metoprolol—Headache—Losartan—coronary artery disease	2.25e-05	0.000179	CcSEcCtD
Metoprolol—Urticaria—Lisinopril—coronary artery disease	2.22e-05	0.000177	CcSEcCtD
Metoprolol—Hypersensitivity—Timolol—coronary artery disease	2.22e-05	0.000176	CcSEcCtD
Metoprolol—Nausea—Furosemide—coronary artery disease	2.21e-05	0.000176	CcSEcCtD
Metoprolol—Asthenia—Ramipril—coronary artery disease	2.21e-05	0.000176	CcSEcCtD
Metoprolol—Abdominal pain—Lisinopril—coronary artery disease	2.21e-05	0.000176	CcSEcCtD
Metoprolol—Body temperature increased—Lisinopril—coronary artery disease	2.21e-05	0.000176	CcSEcCtD
Metoprolol—Pruritus—Ramipril—coronary artery disease	2.18e-05	0.000173	CcSEcCtD
Metoprolol—Asthenia—Timolol—coronary artery disease	2.16e-05	0.000172	CcSEcCtD
Metoprolol—Nausea—Losartan—coronary artery disease	2.13e-05	0.00017	CcSEcCtD
Metoprolol—Pruritus—Timolol—coronary artery disease	2.13e-05	0.000169	CcSEcCtD
Metoprolol—Diarrhoea—Ramipril—coronary artery disease	2.11e-05	0.000168	CcSEcCtD
Metoprolol—Diarrhoea—Timolol—coronary artery disease	2.06e-05	0.000164	CcSEcCtD
Metoprolol—Hypersensitivity—Lisinopril—coronary artery disease	2.06e-05	0.000164	CcSEcCtD
Metoprolol—Dizziness—Ramipril—coronary artery disease	2.04e-05	0.000162	CcSEcCtD
Metoprolol—Asthenia—Lisinopril—coronary artery disease	2e-05	0.000159	CcSEcCtD
Metoprolol—Dizziness—Timolol—coronary artery disease	1.99e-05	0.000158	CcSEcCtD
Metoprolol—Pruritus—Lisinopril—coronary artery disease	1.98e-05	0.000157	CcSEcCtD
Metoprolol—Vomiting—Ramipril—coronary artery disease	1.96e-05	0.000156	CcSEcCtD
Metoprolol—Rash—Ramipril—coronary artery disease	1.94e-05	0.000154	CcSEcCtD
Metoprolol—Dermatitis—Ramipril—coronary artery disease	1.94e-05	0.000154	CcSEcCtD
Metoprolol—Headache—Ramipril—coronary artery disease	1.93e-05	0.000153	CcSEcCtD
Metoprolol—Vomiting—Timolol—coronary artery disease	1.91e-05	0.000152	CcSEcCtD
Metoprolol—Diarrhoea—Lisinopril—coronary artery disease	1.91e-05	0.000152	CcSEcCtD
Metoprolol—Rash—Timolol—coronary artery disease	1.9e-05	0.000151	CcSEcCtD
Metoprolol—Dermatitis—Timolol—coronary artery disease	1.9e-05	0.000151	CcSEcCtD
Metoprolol—Headache—Timolol—coronary artery disease	1.89e-05	0.00015	CcSEcCtD
Metoprolol—Dizziness—Lisinopril—coronary artery disease	1.85e-05	0.000147	CcSEcCtD
Metoprolol—Nausea—Ramipril—coronary artery disease	1.83e-05	0.000146	CcSEcCtD
Metoprolol—Nausea—Timolol—coronary artery disease	1.79e-05	0.000142	CcSEcCtD
Metoprolol—Vomiting—Lisinopril—coronary artery disease	1.78e-05	0.000141	CcSEcCtD
Metoprolol—Rash—Lisinopril—coronary artery disease	1.76e-05	0.00014	CcSEcCtD
Metoprolol—Dermatitis—Lisinopril—coronary artery disease	1.76e-05	0.00014	CcSEcCtD
Metoprolol—Headache—Lisinopril—coronary artery disease	1.75e-05	0.000139	CcSEcCtD
Metoprolol—Nausea—Lisinopril—coronary artery disease	1.66e-05	0.000132	CcSEcCtD
Metoprolol—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	3.87e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HBA1—coronary artery disease	3.87e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDOA—coronary artery disease	3.87e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOC3—coronary artery disease	3.85e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LDLR—coronary artery disease	3.83e-06	0.000108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	3.82e-06	0.000108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.82e-06	0.000108	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—coronary artery disease	3.8e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	3.8e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	3.79e-06	0.000107	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC9A1—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LIPC—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HBA1—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2C19—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3C2A—coronary artery disease	3.78e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	3.77e-06	0.000106	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DCN—coronary artery disease	3.76e-06	0.000106	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOC3—coronary artery disease	3.76e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	3.75e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	3.74e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	3.74e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	3.74e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCLC—coronary artery disease	3.74e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CETP—coronary artery disease	3.74e-06	0.000105	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LDLR—coronary artery disease	3.73e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	3.71e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	3.71e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SDC1—coronary artery disease	3.69e-06	0.000104	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—coronary artery disease	3.69e-06	0.000104	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.69e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	3.68e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	3.68e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	3.66e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	3.66e-06	0.000103	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.66e-06	0.000103	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCLC—coronary artery disease	3.65e-06	0.000103	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CETP—coronary artery disease	3.65e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	3.63e-06	0.000102	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—coronary artery disease	3.61e-06	0.000102	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SDC1—coronary artery disease	3.61e-06	0.000102	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	3.6e-06	0.000101	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	3.6e-06	0.000101	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	3.58e-06	0.000101	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.58e-06	0.000101	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LIPC—coronary artery disease	3.56e-06	0.0001	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HBA1—coronary artery disease	3.56e-06	0.0001	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.56e-06	0.0001	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.56e-06	0.0001	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOC3—coronary artery disease	3.54e-06	9.99e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—coronary artery disease	3.54e-06	9.98e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LDLR—coronary artery disease	3.52e-06	9.93e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	3.51e-06	9.89e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—coronary artery disease	3.5e-06	9.87e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	3.5e-06	9.87e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PSMB5—coronary artery disease	3.49e-06	9.85e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PSMA6—coronary artery disease	3.49e-06	9.85e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.48e-06	9.83e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	3.48e-06	9.82e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.48e-06	9.81e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.48e-06	9.81e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCLC—coronary artery disease	3.44e-06	9.69e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CETP—coronary artery disease	3.44e-06	9.69e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	3.42e-06	9.65e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	3.42e-06	9.64e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CTGF—coronary artery disease	3.41e-06	9.62e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PSMB5—coronary artery disease	3.41e-06	9.61e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PSMA6—coronary artery disease	3.41e-06	9.61e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	3.41e-06	9.61e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SDC1—coronary artery disease	3.4e-06	9.59e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMGCR—coronary artery disease	3.38e-06	9.53e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GOT2—coronary artery disease	3.38e-06	9.53e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	3.35e-06	9.44e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	3.34e-06	9.43e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—C3—coronary artery disease	3.34e-06	9.42e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CTGF—coronary artery disease	3.33e-06	9.39e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMGCR—coronary artery disease	3.3e-06	9.3e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GOT2—coronary artery disease	3.3e-06	9.3e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	3.27e-06	9.23e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—C3—coronary artery disease	3.27e-06	9.22e-05	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.23e-06	9.12e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.21e-06	9.06e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.21e-06	9.06e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	3.19e-06	8.99e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	3.17e-06	8.95e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CTGF—coronary artery disease	3.14e-06	8.85e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	3.12e-06	8.79e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	3.11e-06	8.77e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	3.11e-06	8.77e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GOT2—coronary artery disease	3.11e-06	8.77e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.11e-06	8.77e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLCB1—coronary artery disease	3.11e-06	8.77e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	3.11e-06	8.76e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—coronary artery disease	3.08e-06	8.7e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	3.07e-06	8.67e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.05e-06	8.6e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	3.05e-06	8.6e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	3.04e-06	8.58e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	3.04e-06	8.58e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—coronary artery disease	3.04e-06	8.58e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLCB1—coronary artery disease	3.03e-06	8.56e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	3.03e-06	8.54e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCA1—coronary artery disease	3.01e-06	8.5e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	3.01e-06	8.48e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.98e-06	8.41e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.97e-06	8.38e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.96e-06	8.35e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCA1—coronary artery disease	2.94e-06	8.29e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.93e-06	8.27e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.93e-06	8.27e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.92e-06	8.24e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GOT1—coronary artery disease	2.92e-06	8.23e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GGT1—coronary artery disease	2.92e-06	8.23e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.9e-06	8.19e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.9e-06	8.18e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.87e-06	8.09e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.87e-06	8.09e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.86e-06	8.06e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.86e-06	8.06e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GGT1—coronary artery disease	2.85e-06	8.03e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GOT1—coronary artery disease	2.85e-06	8.03e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.84e-06	8e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.81e-06	7.92e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—coronary artery disease	2.77e-06	7.82e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.77e-06	7.81e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.75e-06	7.75e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2.69e-06	7.6e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GGT1—coronary artery disease	2.68e-06	7.57e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GOT1—coronary artery disease	2.68e-06	7.57e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	2.67e-06	7.54e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	2.67e-06	7.54e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—coronary artery disease	2.65e-06	7.48e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	2.63e-06	7.43e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.62e-06	7.39e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.61e-06	7.37e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	2.61e-06	7.37e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	2.61e-06	7.37e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.61e-06	7.35e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.6e-06	7.32e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.58e-06	7.29e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.57e-06	7.25e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.56e-06	7.21e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—coronary artery disease	2.56e-06	7.21e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	2.56e-06	7.21e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—coronary artery disease	2.55e-06	7.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	2.55e-06	7.19e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.53e-06	7.15e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—coronary artery disease	2.52e-06	7.11e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	2.51e-06	7.09e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	2.5e-06	7.06e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—coronary artery disease	2.49e-06	7.02e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOB—coronary artery disease	2.48e-06	6.98e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.44e-06	6.89e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	2.44e-06	6.88e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—coronary artery disease	2.43e-06	6.84e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOB—coronary artery disease	2.42e-06	6.81e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.41e-06	6.8e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.41e-06	6.79e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.39e-06	6.74e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.39e-06	6.74e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	2.39e-06	6.73e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.38e-06	6.7e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPL—coronary artery disease	2.36e-06	6.67e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	2.36e-06	6.66e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—coronary artery disease	2.35e-06	6.63e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—coronary artery disease	2.35e-06	6.62e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	2.33e-06	6.57e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	2.31e-06	6.52e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPL—coronary artery disease	2.31e-06	6.51e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—coronary artery disease	2.31e-06	6.5e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	2.28e-06	6.43e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOB—coronary artery disease	2.28e-06	6.42e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	2.26e-06	6.39e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—coronary artery disease	2.25e-06	6.35e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD36—coronary artery disease	2.25e-06	6.33e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	2.22e-06	6.26e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.22e-06	6.26e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	2.22e-06	6.25e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.21e-06	6.25e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD36—coronary artery disease	2.19e-06	6.18e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPL—coronary artery disease	2.17e-06	6.13e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	2.17e-06	6.12e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.16e-06	6.11e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.13e-06	6e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—coronary artery disease	2.12e-06	5.98e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—coronary artery disease	2.08e-06	5.86e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	2.07e-06	5.83e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD36—coronary artery disease	2.07e-06	5.83e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.04e-06	5.75e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—coronary artery disease	2.02e-06	5.7e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	2.02e-06	5.7e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	2e-06	5.63e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—coronary artery disease	1.98e-06	5.59e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.98e-06	5.58e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—coronary artery disease	1.97e-06	5.57e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.97e-06	5.54e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—coronary artery disease	1.96e-06	5.52e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.96e-06	5.52e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.95e-06	5.51e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.94e-06	5.46e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—coronary artery disease	1.93e-06	5.45e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.93e-06	5.43e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.92e-06	5.42e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—coronary artery disease	1.91e-06	5.39e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.88e-06	5.31e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.88e-06	5.29e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.87e-06	5.27e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—coronary artery disease	1.86e-06	5.25e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.83e-06	5.16e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—coronary artery disease	1.82e-06	5.14e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.81e-06	5.11e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—coronary artery disease	1.8e-06	5.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.77e-06	5e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—coronary artery disease	1.73e-06	4.87e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—coronary artery disease	1.7e-06	4.8e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—coronary artery disease	1.68e-06	4.75e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.68e-06	4.74e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—coronary artery disease	1.66e-06	4.69e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.64e-06	4.63e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—coronary artery disease	1.59e-06	4.48e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—coronary artery disease	1.57e-06	4.42e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—coronary artery disease	1.55e-06	4.38e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.54e-06	4.35e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—coronary artery disease	1.51e-06	4.27e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.51e-06	4.26e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.51e-06	4.25e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—coronary artery disease	1.49e-06	4.21e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—coronary artery disease	1.48e-06	4.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.48e-06	4.17e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—coronary artery disease	1.45e-06	4.09e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—coronary artery disease	1.43e-06	4.03e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—coronary artery disease	1.37e-06	3.85e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.36e-06	3.83e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—coronary artery disease	1.32e-06	3.74e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-06	3.7e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.28e-06	3.62e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.25e-06	3.52e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—coronary artery disease	1.22e-06	3.44e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	1.16e-06	3.27e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	1.14e-06	3.2e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	1.07e-06	3.02e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	1.05e-06	2.96e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—coronary artery disease	8.35e-07	2.36e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—coronary artery disease	8.15e-07	2.3e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.68e-07	2.17e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—coronary artery disease	6.82e-07	1.92e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—coronary artery disease	6.66e-07	1.88e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—coronary artery disease	6.28e-07	1.77e-05	CbGpPWpGaD
